Beyond the time window of intravenous thrombolysis: standing by or by stenting? [0.03%]
静脉溶栓时间窗外：等待还是支架置入？
Xinfeng Liu
Xinfeng Liu
Intravenous administration of tissue plasminogen activator within 4.5 h of symptom onset is presently the 'golden rule' for treating acute ischemic stroke. However, many patients miss the time window and others reject this treatment due to ...
X Liu,M G Hennerici
X Liu
Idiopathic Intracranial Hypertension. A Systematic Analysis of Transverse Sinus Stenting [0.03%]
特发性颅内高压的系统性分析：静脉窦支架置入术治疗疗效及作用机制探讨
Mohamed S Teleb,Matthew E Cziep,Marc A Lazzaro et al.
Mohamed S Teleb et al.
Background: Idiopathic intracranial hypertension (IIH) is a disorder characterized by signs and symptoms of increased intracranial pressure without structural cause seen on conventional imaging. Hallmark treatment after f...
Stenting and angioplasty of small cerebral arteries in symptomatic intracranial atherosclerotic disease [0.03%]
症状性颅内动脉粥样硬化狭窄的支架成形术及球囊成形术治疗
Osama O Zaidat,Junaid Kalia,Emad Nourollah-Zadeh et al.
Osama O Zaidat et al.
Background: Intracranial atherosclerotic disease (ICAD) is a common cause of stroke with a poor natural history despite medical therapy. Few studies have investigated endovascular therapies for the treatment of symptomati...
David S Liebeskind,Edward Feldmann
David S Liebeskind
There is an urgent need for stroke experts to advance the care of their patients, yet current approaches are outmoded and have not been successful. The traditional emphasis on anatomical identification of disease, using percent luminal sten...